Cargando…
A genome-engineered bioartificial implant for autoregulated anticytokine drug delivery
Biologic drug therapies are increasingly used for inflammatory diseases such as rheumatoid arthritis but may cause significant adverse effects when delivered continuously at high doses. We used CRISPR-Cas9 genome editing of iPSCs to create a synthetic gene circuit that senses changing levels of endo...
Autores principales: | Choi, Yun-Rak, Collins, Kelsey H., Springer, Luke E., Pferdehirt, Lara, Ross, Alison K., Wu, Chia-Lung, Moutos, Franklin T., Harasymowicz, Natalia S., Brunger, Jonathan M., Pham, Christine T. N., Guilak, Farshid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442875/ https://www.ncbi.nlm.nih.gov/pubmed/34516920 http://dx.doi.org/10.1126/sciadv.abj1414 |
Ejemplares similares
-
Synthetic gene circuits for preventing disruption of the circadian clock due to interleukin-1–induced inflammation
por: Pferdehirt, Lara, et al.
Publicado: (2022) -
Biological resurfacing in a canine model of hip osteoarthritis
por: Estes, Bradley T., et al.
Publicado: (2021) -
Gene therapy for follistatin mitigates systemic metabolic inflammation and post-traumatic arthritis in high-fat diet–induced obesity
por: Tang, Ruhang, et al.
Publicado: (2020) -
Hydrogel Encapsulation of Genome-Engineered Stem Cells for Long-Term Self-Regulating Anti-Cytokine Therapy
por: Collins, Kelsey H., et al.
Publicado: (2023) -
High-impact FN1 mutation decreases chondrogenic potential and affects cartilage deposition via decreased binding to collagen type II
por: van Hoolwerff, Marcella, et al.
Publicado: (2021)